Mylan Institutional Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN INSTITUTIONAL, and what generic and branded alternatives to MYLAN INSTITUTIONAL drugs are available?
MYLAN INSTITUTIONAL has forty-six approved drugs.
Summary for Mylan Institutional
US Patents: | 0 |
Tradenames: | 41 |
Ingredients: | 39 |
NDAs: | 46 |
Patent Litigation for Mylan Institutional: | See patent lawsuits for Mylan Institutional |
PTAB Cases with Mylan Institutional as petitioner: | See PTAB cases with Mylan Institutional as petitioner |
Drugs and US Patents for Mylan Institutional
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Institutional | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | INJECTABLE;INJECTION | 040471-001 | Nov 21, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Mylan Institutional | MEFOXIN | cefoxitin sodium | INJECTABLE;INJECTION | 050517-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Mylan Institutional | ULTIVA | remifentanil hydrochloride | INJECTABLE;INJECTION | 020630-001 | Jul 12, 1996 | AP | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Institutional | DURACLON | clonidine hydrochloride | INJECTABLE;INJECTION | 020615-001 | Oct 2, 1996 | AP | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Institutional | DIPHENHYDRAMINE HYDROCHLORIDE | diphenhydramine hydrochloride | INJECTABLE;INJECTION | 040498-001 | Jul 12, 2005 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Institutional | IBUTILIDE FUMARATE | ibutilide fumarate | INJECTABLE;INJECTION | 090643-001 | Jan 11, 2010 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Mylan Institutional
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan Institutional | ULTIVA | remifentanil hydrochloride | INJECTABLE;INJECTION | 020630-003 | Jul 12, 1996 | 5,019,583*PED | ⤷ Try a Trial |
Mylan Institutional | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019677-001 | Nov 6, 1991 | 4,952,586 | ⤷ Try a Trial |
Mylan Institutional | ULTIVA | remifentanil hydrochloride | INJECTABLE;INJECTION | 020630-002 | Jul 12, 1996 | 5,019,583*PED | ⤷ Try a Trial |
Mylan Institutional | ULTIVA | remifentanil hydrochloride | INJECTABLE;INJECTION | 020630-002 | Jul 12, 1996 | 5,466,700*PED | ⤷ Try a Trial |
Mylan Institutional | ULTIVA | remifentanil hydrochloride | INJECTABLE;INJECTION | 020630-002 | Jul 12, 1996 | 5,866,591*PED | ⤷ Try a Trial |
Mylan Institutional | ULTIVA | remifentanil hydrochloride | INJECTABLE;INJECTION | 020630-001 | Jul 12, 1996 | 5,866,591*PED | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for MYLAN INSTITUTIONAL drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
➤ Subscribe | for Injection | 1 mg/vial, 2 mg/vial and 5 mg/vial | ➤ Subscribe | 2013-12-27 |
➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
Similar Applicant Names
Here is a list of applicants with similar names.